123 related articles for article (PubMed ID: 7524236)
1. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.
Jacobsen SJ; Lilja H; Klee GG; Wright GL; Pettersson K; Oesterling JE
Urology; 1994 Oct; 44(4):512-8. PubMed ID: 7524236
[TBL] [Abstract][Full Text] [Related]
2. Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time.
Jacobsen SJ; Klee GG; Lilja H; Wright GL; Oesterling JE
Urology; 1995 Mar; 45(3):447-53. PubMed ID: 7533456
[TBL] [Abstract][Full Text] [Related]
3. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx.
Oesterling JE; Moyad MA; Wright GL; Beck GR
Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
[TBL] [Abstract][Full Text] [Related]
5. Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.
Oesterling JE; Jacobsen SJ; Klee GG; Pettersson K; Piironen T; Abrahamsson PA; Stenman UH; Dowell B; Lövgren T; Lilja H
J Urol; 1995 Sep; 154(3):1090-5. PubMed ID: 7543605
[TBL] [Abstract][Full Text] [Related]
6. Measurement of prostate-specific antigen in serum using four different immunoassays.
Cattini R; Robinson D; Gill O; Jolley N; Bacarese-Hamilton T
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):181-5. PubMed ID: 7518258
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
Vessella RL; Noteboom J; Lange PH
Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
[TBL] [Abstract][Full Text] [Related]
9. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
[TBL] [Abstract][Full Text] [Related]
10. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen.
Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB
Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457
[TBL] [Abstract][Full Text] [Related]
11. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W
Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619
[TBL] [Abstract][Full Text] [Related]
12. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
[TBL] [Abstract][Full Text] [Related]
13. Reliability analysis of first and second generation PSA assays.
Wymenga LF; Groenier K; Visser-van Brummen P; Marrink J; Mensink HJ
Can J Urol; 2000 Aug; 7(4):1070-6. PubMed ID: 11109077
[TBL] [Abstract][Full Text] [Related]
14. Measurement of serum prostate specific antigen using IMx prostate specific antigen assay.
Klee GG; Dodge LA; Zincke H; Oesterling JE
J Urol; 1994 Jan; 151(1):94-8. PubMed ID: 7504749
[TBL] [Abstract][Full Text] [Related]
15. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
Wener MH; Daum PR; Brawer MK
Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
[TBL] [Abstract][Full Text] [Related]
16. Assay variability in serum prostate-specific antigen determination.
Brawer MK; Daum P; Petteway JC; Wener MH
Prostate; 1995 Jul; 27(1):1-6. PubMed ID: 7541527
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
Schambeck CM
Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three commercial PSA assays: results of restandardization of the Ciba Corning method.
Brawer MK; Bankson DD; Haver VM; Petteway JC
Prostate; 1997 Mar; 30(4):269-73. PubMed ID: 9111605
[TBL] [Abstract][Full Text] [Related]
19. [Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients)].
de la Taille A; Houlgatte A; Houdelette P; Berlizot P; Ramirez J; Ricordel I
Prog Urol; 1997 Apr; 7(2):240-5. PubMed ID: 9264766
[TBL] [Abstract][Full Text] [Related]
20. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]